North America PDX Models Market _Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025

June 2018 | 100 pages | ID: N33827F59FAEN
Data Bridge Market Research

Abstracts

North America PDX models market is expected to hold the leading market share in the forecast period of 2018 to 2025. The new market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.

Prominent factors driving the growth of this market consist of rising number of pharmaceutical R&D activities in cancer research, advantages offered by PDX models offer compared with the classic approach, rising need for personalized medicine and increasing support for cancer research activities from government and non-government organization.

The key market players for North America PDX models market are listed below:

• Crown Bioscience Inc.
• The Jackson Laboratory
• Champion Oncology, Inc.
• Charles River
• Oncodesign
• Wuxi AppTec
• Horizon Discovery Group plc
• Pharmatest Services
• Hera Biolabs
• EPO Berlin-Buch GmbH
• Xentech
• Urolead
• Creative Animodel
• EUROPDX
• MI Bioresearch Inc
• Aragen Bioscience

The market is further segmented into:

• Type
• Tumor Type
• Application
• End User

The North America PDX models market is segmented based on type into two notable segments; mice models and rat models. In 2018, mice models segment is valued to rule with the highest market share by 2025.

The North America PDX models market is segmented in tumor type categories into six notable segments; respiratory tumor models, urological tumor models, gastrointestinal tumor models, hematological tumor models, gynecological tumor models and others. In 2018, respiratory tumor models segment is valued to rule with the highest market shares by 2025, rising at the highest CAGR.

The North America PDX models market is segmented in application into preclinical drug development and oncology research and biomarker analysis. In 2018, preclinical drug development and oncology research segment is valued to rule with highest market shares and rising at the highest CAGR.

The North America PDX models market is segmented in end user into contract research organization (CRO), academic and research institutions and pharmaceutical and biotechnology companies. In 2018, contract research organization (CRO) segment is valued to rule with highest market shares and rising at the highest CAGR.

Based on geography, the market is segmented into:

• U.S.
• Canada
• Mexico

Covered in this report

The report covers the present scenario and the growth prospects of the North America PDX models for 2018-2025. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.

You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

Contents

1 INTRODUCTION

1.1 Objectives Of The Study
1.2 Market Definition
1.3 Overview Of North America Pdx Models Market
1.4 Currency And Pricing
1.5 Limitation
1.6 Markets Coveredss

2 MARKET SEGMENTATION

2.1 Markets Covered
2.2 Geographic Scope
2.3 Years Considered For The Study
2.4 Currency And Pricing
2.5 Research Methodology
2.6 Primary Interviews With Key Opinion Leaders
2.7 Secondary Sources
2.8 Assumptions

3 MARKET OVERVIEW

3.1 Drivers
  3.1.1 Rising Number Of Pharmaceutical R&D Activities In Cancer Research
  3.1.2 Pdx Models Offer Advantages As Compared With The Classic Approach
  3.1.3 Rising Need For Personalized Medicine
  3.1.4 Increasing Support For Cancer Research Activities From Government And Non-Government Organization
3.2 Restraints
  3.2.1 High Cost Of Pdx Models
  3.2.2 Strict Regulation With Respect To The Utilization Of Animal Models In Cancer Research
3.3 Opprtunities
  3.3.1 Increasing Demand For Humanized Pdx Models
3.4 Challenges
  3.4.1 Limitations Of Pdx Models

4 EXECUTIVE SUMMARY

5 PREMIUM INSIGHTS

6 NORTH AMERICA PDX MODELS MARKET, BY TYPE

6.1 Overview
6.2 Mice Models
6.3 Rat Models

7 NORTH AMERICA PDX MODELS MARKET, BY TUMOR TYPE

7.1 Overview
7.2 Gastrointestinal Tumor Models
7.3 Gynecological Tumor Models
7.4 Respiratory Tumor Models
7.5 Urological Tumor Models
7.6 Hematological Tumor Models
7.7 Others

8 NORTH AMERICA PDX MODELS MARKET, BY APPLICATION

8.1 Overview
8.2 Preclinical Drug Development And Oncology Research
8.3 Biomarker Analysis

9 NORTH AMERICA PDX MODELS MARKET, BY END USER

9.1 Overview
9.2 Contract Research Organizations
9.3 Pharmaceutical And Biotechnology Companies
9.4 Academic And Research Institutions

10 NORTH AMERICA PDX MODELS MARKET, BY GEOGRAPHY

10.1 North America
  10.1.1 U.S.
  10.1.2 Canada
  10.1.3 Mexico

11 NORTH AMERICA PDX MODELS MARKET, COMPANY LANDSCAPE

11.1 Company Share Analysis: North America

12 COMPANY PROFILES

12.1 Charles River
  12.1.1 Company Overview
  12.1.2 Revenue Analysis
  12.1.3 Company Share Analysis
  12.1.4 Product Portfolio
  12.1.5 Recent Developments
12.2 Crown Bioscience Inc. (Subsidiary Of Jsr Corporation)
  12.2.1 Company Overview
  12.2.2 Geographic Presence
  12.2.3 Company Share Analysis
  12.2.4 Product Portfolio
  12.2.5 Recent Developments
12.3 Champion Oncology, Inc
  12.3.1 Company Overview
  12.3.2 Revenue Analysis
  12.3.3 Company Share Analysis
  12.3.4 Product Portfolio
  12.3.5 Recent Developments
12.4 Aragen Bioscience (Subsidiary Of Gvk Biosciences Private Limited)
  12.4.1 Company Overview
  12.4.2 Product Portfolio
  12.4.3 Recent Developments
12.5 Creative Animodel
  12.5.1 Company Overview
  12.5.2 Product Portfolio
  12.5.3 Recent Developments
12.6 Epo Berlin-Buch Gmbh
  12.6.1 Company Overview
  12.6.2 Product Portfolio
  12.6.3 Recent Developments
12.7 Europdx
  12.7.1 Company Overview
  12.7.2 Geographical Presence
  12.7.3 Product Portfolio
  12.7.4 Recent Developments
12.8 Hera Biolabs
  12.8.1 Company Overview
  12.8.2 Product Portfolio
  12.8.3 Recent Developments
12.9 Horizon Discovery Group Plc
  12.9.1 Company Overview
  12.9.2 Revenue Analysis
  12.9.3 Product Portfolio
  12.9.4 Recent Developments
12.10 Mi Bioresearch Inc
  12.10.1 Company Overview
  12.10.2 Product Portfolio
  12.10.3 Recent Developments
12.11 Oncodesign
  12.11.1 Company Overview
  12.11.2 Revenue Analysis
  12.11.3 Product Portfolio
  12.11.4 Recent Developments
12.12 Pharmatest Services Ltd
  12.12.1 Company Overview
  12.12.2 Geographic Presence
  12.12.3 Product Portfolio
  12.12.4 Recent Developments
12.13 The Jackson Laboratory
  12.13.1 Company Overview
  12.13.2 Revenue Analysis
  12.13.3 Product Portfolio
  12.13.4 Recent Developments
12.14 Urolead
  12.14.1 Company Overview
  12.14.2 Product Portfolio
  12.14.3 Recent Developments
12.15 Wuxi Apptec
  12.15.1 Company Overview
  12.15.2 Geographic Presence
  12.15.3 Product Portfolio
  12.15.4 Recent Developments
12.16 Xentech
  12.16.1 Company Overview
  12.16.2 Product Portfolio
  12.16.3 Recent Developments

13 RELATED REPORTS

List Of Tables

LIST OF TABLES

Table 1 North America Pdx Models Market, By Type, 2016– 2025, (Usd Million)
Table 2 North America Mice Models In Pdx Models Market, By Region, 2016-2025, (Usd Million)
Table 3 North America Rat Models In Pdx Models Market, By Region, 2016-2025, (Usd Million)
Table 4 North America Pdx Models Market, By Tumor Type, 2016– 2025 (Usd Million)
Table 5 North America Gastrointestinal Tumor Models Market, By Region, 2016-2025, (Usd Million)
Table 6 North America Gynecological Tumor Models Market, By Region, 2016-2025, (Usd Million)
Table 7 North America Respiratory Tumor Models Market, By Region, 2016-2025, (Usd Million)
Table 8 North America Urological Tumor Models Market, By Region, 2016-2025, (Usd Million)
Table 9 North America Hematological Tumor Models Market, By Region, 2016-2025, (Usd Million)
Table 10 North America Others Tumor Types In Pdx Models Market, By Region, 2016-2025, (Usd Million)
Table 11 North America Pdx Models Market, By Application, 2016– 2025 (Usd Million)
Table 12 North America Preclinical Drug Development And Oncology Research In Pdx Models Market, By Region, 2016-2025, (Usd Million)
Table 13 North America Biomarker Analysis In Pdx Models Market, By Region, 2016-2025, (Usd Million)
Table 14 North America Pdx Models Market, By End User, 2016– 2025, (Usd Million)
Table 15 North America Contract Research Organizations In Pdx Model Market, By Region, 2016-2025, (Usd Million)
Table 16 North America Pharmaceutical And Biotechnology Companies In Pdx Models Market, By Region, 2016-2025, (Usd Million)
Table 17 North America Academic And Research Institutions In Pdx Modela Market, By Region, 2016-2025, (Usd Million)
Table 18 North America Pdx Models Market, By Country, 2016 – 2025, (Usd Million)
Table 19 North America Pdx Models Market, By Type, 2016 – 2025, (Usd Million)
Table 20 North America Pdx Models Market, By Tumor Type, 2016 – 2025, (Usd Million)
Table 21 North America Pdx Models Market, By Application, 2016 – 2025, (Usd Million)
Table 22 North America Pdx Models Market, By End User, 2016 – 2025, (Usd Million)
Table 23 U.S. Pdx Models Market, By Type, 2016 – 2025, (Usd Million)
Table 24 U.S. Pdx Models Market, By Tumor Type, 2016 – 2025, (Usd Million)
Table 25 U.S. Pdx Models Market, By Application, 2016 – 2025, (Usd Million)
Table 26 U.S. Pdx Models Market, By End User, 2016 – 2025, (Usd Million)
Table 27 Canada Pdx Models Market, By Type, 2016 – 2025, (Usd Million)
Table 28 Canada Pdx Models Market, By Tumor Type, 2016 – 2025, (Usd Million)
Table 29 Canada Pdx Models Market, By Application, 2016 – 2025, (Usd Million)
Table 30 Canada Pdx Models Market, By End User, 2016 – 2025, (Usd Million)
Table 31 Mexico Pdx Models Market, By Type, 2016 – 2025, (Usd Million)
Table 32 Mexico Pdx Models Market, By Tumor Type, 2016 – 2025, (Usd Million)
Table 33 Mexico Pdx Models Market, By Application, 2016 – 2025, (Usd Million)
Table 34 Mexico Pdx Models Market, By End User, 2016 – 2025, (Usd Million)

List Of Figures

LIST OF FIGURES

Figure 1 North America Pdx Models Market: Segmentation
Figure 2 North America Pdx Models Market: Data Triangulation
Figure 3 North America Pdx Models Market: Research Snapshot
Figure 4 North America Pdx Models Market: Bottom Up Approach
Figure 5 North America Pdx Models Market: Top Down Approach
Figure 6 North America Pdx Models Market: Interview Demographics
Figure 7 Drivers, Restraints, Opportunities, And Challenges Of Pdx Models Market
Figure 8 Below Mentioned Is R&D Expense By The Jackson Laboratory For Year 2016-17:
Figure 9 North America Pdx Models Market: Segmentation
Figure 10 Rising Number Of Pharmaceutical R&D Activities In Cancer Research And Rising Need For Personalized Medicine Are Expected To Drive The Market For Pdx Models In The Forecast Period 2018 To 2025
Figure 11 Mice Models Is Expected To Account For The Largest Share Of The North America Pdx Models Market In 2018 & 2025
Figure 12 Asia Pacific Is The Maximum Growing And Most Profitable Revenue Pockets For Pdx Models Market In The Forecast Period From 2018 To 2025
Figure 13 North America Pdx Models Market: By Type, 2017
Figure 14 North America Pdx Models Market: By Tyumor Type, 2017
Figure 15 North America Pdx Models Market: By Application, 2017
Figure 16 North America Pdx Models Market: By End User, 2017
Figure 17 North America Pdx Models Market Snapshot (2017)
Figure 18 North America Pdx Models Market: By Country (2017)
Figure 19 North America Pdx Models Market: By Country (2018 & 2025)
Figure 20 North America Pdx Models Market: By Country (2017 & 2025)
Figure 21 North America Pdx Models Market, By Type (2018 - 2025)
Figure 22 North America Pdx Models Market: Company Share 2017(%)